Invitae (OTC:NVTA), backed by Softbank (OTCPK:SFTBY) and Cathie Wood's Ark Investment Management, filed for Chapter 11 bankruptcy protection, to address the genetic-testing company's more than $1B ...
– Using Invitae's Ciitizen patient-driven data platform, AstraZeneca and the Cholangiocarcinoma Foundation will access lived experience of patients with a rare cancer to drive further research – – ...
Spotlight Top Pick InVitae Corp (NYSE:NVTA) has seen its stock decline and one culprit was a recently published article “How a cancer test maker started by former Twitter, Google execs hopes to change ...
Invitae, a San Francisco-based genetic tech company, announced it is laying off more than 700 employees at its headquarters. The layoffs at Invitae are part of a larger corporate restructuring in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback